Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glaucoma medications, glaucoma therapy, and the evolving paradigm

M Fingeret1

  • 1Department of Veterans Affairs, Optometry Section, Brooklyn, New York, USA.

Journal of the American Optometric Association
|April 29, 1998
PubMed
Summary

Modern open-angle glaucoma treatment has evolved significantly since the 1980s, incorporating new medications and procedures. Newer therapies offer improved efficacy and safety profiles for reducing intraocular pressure (IOP).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Patient communication--the hidden procedure in the management of glaucoma.

Optometry (St. Louis, Mo.)·2001
Same author

Kinetic and static fixation methods in automated threshold perimetry.

Journal of glaucoma·1999
Same author

The changing nature of glaucoma.

Optometry and vision science : official publication of the American Academy of Optometry·1999
Same author

Normal aging effects for frequency doubling technology perimetry.

Optometry and vision science : official publication of the American Academy of Optometry·1999
Same author

Comparison of diagnostic performance and fixation control of two automated perimeters.

Journal of the American Optometric Association·1998

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Glaucoma treatment is dynamic, with significant evolution in therapeutic approaches since the 1980s.
  • Topical beta-blockers remain a primary treatment for open-angle glaucoma.
  • Newer medications and modalities supplement traditional therapies.

Purpose of the Study:

  • To compare current open-angle glaucoma treatment methods with those from the 1980s.
  • To highlight advancements in glaucoma pharmacotherapy and surgical interventions.

Main Methods:

  • Review of contemporary and historical treatment strategies for open-angle glaucoma.
  • Evaluation of newly available medications and their efficacy and safety profiles.
  • Assessment of procedures such as argon laser trabeculoplasty (ALT).

Main Results:

  • Topical carbonic anhydrase inhibitors (CAIs) offer efficacy similar to oral forms but with fewer systemic side effects.
  • Brimonidine (topical alpha2-adrenergic agonist) and latanoprost (topical prostaglandin) improve intraocular pressure (IOP) reduction with better therapeutic indices.
  • Argon laser trabeculoplasty (ALT) is a safe and effective method for IOP reduction.

Conclusions:

  • Treatment paradigms for open-angle glaucoma are continuously evolving.
  • Ongoing research into existing and new anti-glaucoma medications will shape future therapeutic strategies.

Related Experiment Videos